214 related articles for article (PubMed ID: 30550532)
1. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.
Pham BH; Marmor MF
Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532
[TBL] [Abstract][Full Text] [Related]
2. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
3. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
[TBL] [Abstract][Full Text] [Related]
6. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
de Sisternes L; Hu J; Rubin DL; Marmor MF
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
[TBL] [Abstract][Full Text] [Related]
7. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
9. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
10. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
Ahn SJ; Ryu SJ; Lim HW; Lee BR
Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
[TBL] [Abstract][Full Text] [Related]
11. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
12. Pericentral hydroxychloroquine retinopathy in Korean patients.
Lee DH; Melles RB; Joe SG; Lee JY; Kim JG; Lee CK; Yoo B; Koo BS; Kim JT; Marmor MF; Yoon YH
Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
14. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
[TBL] [Abstract][Full Text] [Related]
16. Multimodal imaging in a severe case of hydroxychloroquine toxicity.
Bhavsar KV; Mukkamala LK; Freund KB
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):377-9. PubMed ID: 25856825
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
Greenstein VC; Lima de Carvalho JR; Parmann R; Amaro-Quireza L; Lee W; Hood DC; Tsang SH; Sparrow JR
Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):41. PubMed ID: 32976563
[TBL] [Abstract][Full Text] [Related]
18. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
[TBL] [Abstract][Full Text] [Related]
19. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
